Jove
Visualize
Contact Us

Related Experiment Videos

Interferon-induced pulmonary sarcoidosis.

R Farah1, R Farah, N Makhoul

  • 1Department of Internal Medicine F, Western Galilee Hospital, RO.Box 21, Nahariya 22100, Israel. raymond_farah@yahoo.com

International Journal of Clinical Pharmacology and Therapeutics
|September 17, 2005
PubMed
Summary

Interferon therapy for chronic hepatitis C can cause sarcoidosis. This interferon-induced sarcoidosis is increasingly reported, particularly in patients with chronic hepatitis C, suggesting a growing association.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher Short- and Long-Term Fluent Reading Abilities Following an Executive Functions-Based Reading Intervention Are Moderated by Executive Functions Improvement in Children With Reading Difficulties.

Dyslexia (Chichester, England)·2025
Same author

Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: a Big Data analysis of the World Health Organization VigiBase.

European review for medical and pharmacological sciences·2021
Same author

Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.

Familial cancer·2021
Same author

Efficient in-house 3D printing of an orthognathic splint for single-jaw cases.

International journal of oral and maxillofacial surgery·2021
Same author

Stroke symptoms impact on mental and physical health: A Lebanese population based study.

Revue neurologique·2020
Same author

Nonalcoholic fatty liver disease as a risk factor for Clostridium difficile-associated diarrhea.

QJM : monthly journal of the Association of Physicians·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Hepatology
  • Immunology
  • Dermatology

Background:

  • Chronic hepatitis C (CHC) is a significant global health concern.
  • Interferon (IFN) therapy has been a cornerstone treatment for CHC.
  • Sarcoidosis is an inflammatory disease of unknown etiology.

Observation:

  • A new case of sarcoidosis emerged during interferon treatment for CHC.
  • Over 20 cases of interferon-induced sarcoidosis have been documented recently.
  • Approximately 50% of these cases involve patients with CHC.

Findings:

  • The incidence of sarcoidosis associated with interferon therapy appears higher than previously recognized.
  • The increased reporting may be linked to wider IFN use and improved diagnostic techniques.

Related Experiment Videos

  • Chronic hepatitis C patients are a notable demographic for this adverse event.

    • Implications:

    • Clinicians should consider sarcoidosis in patients with CHC undergoing interferon therapy presenting with relevant symptoms.
    • Enhanced diagnostic vigilance may be necessary for interferon-induced sarcoidosis.
    • Further research into the mechanisms of IFN-induced sarcoidosis is warranted.